The store will not work correctly when cookies are disabled.
N-cyclopentyl-2-(pyridin-4-yl)pyrido[3,4-d]pyrimidin-4-amine
ID: ALA4547445
PubChem CID: 135368704
Max Phase: Preclinical
Molecular Formula: C17H17N5
Molecular Weight: 291.36
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: c1cc(-c2nc(NC3CCCC3)c3ccncc3n2)ccn1
Standard InChI: InChI=1S/C17H17N5/c1-2-4-13(3-1)20-17-14-7-10-19-11-15(14)21-16(22-17)12-5-8-18-9-6-12/h5-11,13H,1-4H2,(H,20,21,22)
Standard InChI Key: OCRGFIAWWYJUTP-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 25 0 0 0 0 0 0 0 0999 V2000
6.6242 -11.3334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7915 -12.9884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7904 -13.8120 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5025 -14.2210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5007 -12.5754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2135 -12.9848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2142 -13.8079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9269 -14.2150 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6352 -13.8041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6304 -12.9779 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9213 -12.5704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3486 -14.2100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3469 -15.0283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0595 -15.4382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7707 -15.0227 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7649 -14.1972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0517 -13.7951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9170 -11.7491 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3780 -11.6570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9221 -11.0431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5064 -10.3358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7054 -10.5128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 7 2 0
6 5 2 0
5 2 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
9 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
11 18 1 0
18 1 1 0
1 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 1 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 291.36 | Molecular Weight (Monoisotopic): 291.1484 | AlogP: 3.44 | #Rotatable Bonds: 3 |
Polar Surface Area: 63.59 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.31 | CX LogP: 2.78 | CX LogD: 2.78 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.80 | Np Likeness Score: -1.25 |
References
1. (2018) 6-6 Fused Bicyclic Heteroaryl Compounds and their Use as LATS Inhibitors, |